Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis

Abstract

BackgroundClinical prediction models are increasingly used to predict outcomes such as survival in cancer patients. The aim of this study was threefold. First, to perform a systematic review to identify available clinical prediction models for patients with esophageal and/or gastric cancer. Second, to evaluate sources of bias in the included studies. Third, to investigate the predictive performance of the prediction models using meta-analysis.MethodsMEDLINE, EMBASE, PsycINFO, CINAHL, and The Cochrane Library were searched for publications from the year 2000 onwards. Studies describing models predicting survival, adverse events and/or health-related quality of life (HRQoL) for esophageal or gastric cancer patients were included. Potential sources of bias were assessed and a meta-analysis, pooled per prediction model, was performed on the discriminative abilities (c-indices).ResultsA total of 61 studies were included (45 development and 16 validation studies), describing 47 prediction models. Most models predicted survival after a curative resection. Nearly 75% of the studies exhibited bias in at least 3 areas and model calibration was rarely reported. The meta-analysis showed that the averaged c-index of the models is fair (0.75) and ranges from 0.65 to 0.85.ConclusionMost available prediction models only focus on survival after a curative resection, which is only relevant to a limited patient population. Few models predicted adverse events after resection, and none focused on patient’s HRQoL, despite its relevance. Generally, the quality of reporting is poor and external model validation is limited. We conclude that there is a need for prediction models that better meet patients’ information needs, and provide information on both the benefits and harms of the various treatment options in terms of survival, adverse events and HRQoL.

Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis

“…When specific symptoms are present, such as diarrhea, these could be addressed immediately. Predictive QoL parameters may be added to prediction models for survival, 44,45 in addition to patient, tumor, and treatment characteristics, to improve their predictive outcome. Finally, QoL parameters may be considered as a stratification factor in clinical trials and should be included in the core set of mandatory baseline measurements.…”

Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer

“…Previous systematic reviews of prediction models in oncology also concluded that external validation studies are lacking. Most prediction models provide a probability by using a score, nomogram or calculator (assistive), rather than recommending a treatment decision to the clinician (directive).…”

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

“…dose administration, timeline of use) are still needed [ 22 ]. Predicting patients’ prognoses via blood based biopsies, epigenetics, and autoantibodies still lack validity in locally advanced EC, requiring further investigation into potential progression biomarkers to improve patients’ treatment plans and outcomes [ 23 ].…”